By proceeding, you agree to our Terms of Use and Privacy Policy.
Emilie Plantamura is currently working as Head of Clinical Development at MaaT Pharma.
Talks About #immunology #hypersensitivity
Preferred Locations #Europe
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.